Outsourcing in Clinical Trials CanadaWednesday 14th - Thursday 15th November 2012, Toronto, Canada
Arena International’s Outsourcing in Clinical Trials Canada conference aims to help sponsors improve and perfect their trial models by opening up lines of communication and sharing expertise on industry challenges. In-depth industry research with small to mid-size pharmaceutical and biotech companies allows us to formulate targeted presentations which address the greatest challenges of clinical outsourcing head-on, and give them the opportunity to utilize and incorporate relevant strategies into their trial processes.Read More...
Arena International is pleased to announce that Outsourcing in Clinical Trials Canada has been featured in it’s own supplement and distributed in the September 2012 issue of Pharma Technology Focus. Pharma Technology Focus is an online publication powered by http://www.pharmaceutical-technology.com/.
The aim of the conference is to collectively target all the challenges and issues faced by professionals in the industry to provide an array of solutions and methodologies that have been proven to overcome them.
Small-Mid level Biotech and Pharmaceutical professionals in Canada:
The country is an attractive market for CROs due to its good clinical infrastructure, cost compliance, large population. A new report by GBI Research shows that MNC pharma companies and Contract Research Organizations (CROs) are making more investments in a new clinical research destination: Argentina.
MONTREAL - A strong lifeline is being thrown to Quebec’s struggling biotech industry by U.S.-based drug giant Merck & Co. in partnership with Montreal venture fund manager Teralys Capital and other institutional investors.
Director, Preclinical & Clinical Studies, Medicago
Chief Financial Officer, Affinium Pharmaceutical
Chief Medical Officer, Thrasos Innovation inc
Dr. Andreas Orfanos is the Chief Medical Officer, at Thrasos Innovation Inc. a bio-therapeutics company focused on the discovery and ...